Literature DB >> 22500536

Factors leading to excessive polypharmacy.

Bo Hovstadius1, Göran Petersson.   

Abstract

There are numerous risk factors for patients to develop excessive polypharmacy. The most prominent risk factors are associated with sociodemographics and the patients’ conditions. Risk factors associated with patient behavior, such as patient’s self medication with all types of medications, have not been observed to the same extent but might be at the same level of importance for patients developing excessive polypharmacy. Risk factors related to physicians, and the interaction between patient and physician, are studied to a much lesser extent. The few studies conducted regarding the large variation in physicians’ individual prescribing practices, in terms of polypharmacy, add another perspective to the complexity of the area. Interventions aiming to improve communication between GP and hospital specialist, to create support systems for medical reviews that include all patients’ medications, and to improve the knowledge of multiple prescribing might have the largest potential to better manage excessive polypharmacy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22500536     DOI: 10.1016/j.cger.2012.01.001

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  35 in total

1.  Polypharmacy in Assisted Living and Impact on Clinical Outcomes.

Authors:  Barbara Resnick; Elizabeth Galik; Marie Boltz; Sarah Holmes; Steven Fix; Erin Vigne; Shijun Zhu; Regina Lewis
Journal:  Consult Pharm       Date:  2018-06-01

2.  Optimizing elderly pharmacotherapy: polypharmacy vs. undertreatment. Are these two concepts related?

Authors:  Encarnación Blanco-Reina; Gabriel Ariza-Zafra; Ricardo Ocaña-Riola; Matilde León-Ortíz; Inmaculada Bellido-Estévez
Journal:  Eur J Clin Pharmacol       Date:  2014-11-09       Impact factor: 2.953

3.  The "iatrogenic triad": polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults.

Authors:  Priscila Horta Novaes; Danielle Teles da Cruz; Alessandra Lamas Granero Lucchetti; Isabel Cristina Gonçalves Leite; Giancarlo Lucchetti
Journal:  Int J Clin Pharm       Date:  2017-04-28

4.  Medication Exposure and Health Outcomes in Older Patients with End-Stage Kidney Disease: A Prospective Study Undertaken in New Zealand.

Authors:  Sashika Samaranayaka; Robert J Walker; Ari Samaranayaka; Sarah Derrett; John W B Schollum
Journal:  Drugs Aging       Date:  2018-11       Impact factor: 3.923

Review 5.  Polypharmacy and potentially inappropriate medication use in geriatric oncology.

Authors:  Manvi Sharma; Kah Poh Loh; Ginah Nightingale; Supriya G Mohile; Holly M Holmes
Journal:  J Geriatr Oncol       Date:  2016-08-03       Impact factor: 3.599

Review 6.  Deprescribing in Older Adults With Cardiovascular Disease.

Authors:  Ashok Krishnaswami; Michael A Steinman; Parag Goyal; Andrew R Zullo; Timothy S Anderson; Kim K Birtcher; Sarah J Goodlin; Mathew S Maurer; Karen P Alexander; Michael W Rich; Jennifer Tjia
Journal:  J Am Coll Cardiol       Date:  2019-05-28       Impact factor: 24.094

7.  Epidemiology of Polypharmacy and Potential Drug-Drug Interactions Among Pediatric Patients in ICUs of U.S. Children's Hospitals.

Authors:  Dingwei Dai; James A Feinstein; Wynne Morrison; Athena F Zuppa; Chris Feudtner
Journal:  Pediatr Crit Care Med       Date:  2016-05       Impact factor: 3.624

8.  Geographical differences in the prevalence of chronic polypharmacy in older people: eleven years of the EPIFARM-Elderly Project.

Authors:  Carlotta Franchi; Massimo Cartabia; Paolo Risso; Daniela Mari; Mauro Tettamanti; Alberto Parabiaghi; Luca Pasina; Codjo Djignefa Djade; Ida Fortino; Angela Bortolotti; Luca Merlino; Alessandro Nobili
Journal:  Eur J Clin Pharmacol       Date:  2013-03-28       Impact factor: 2.953

9.  Measuring the impact of long-term medicines use from the patient perspective.

Authors:  Janet Krska; Charles W Morecroft; Philip H Rowe; Helen Poole
Journal:  Int J Clin Pharm       Date:  2014-07-05

Review 10.  Pharmacotherapy Pearls in Rheumatology for the Care of Older Adult Patients: Focus on Oral Disease-Modifying Antirheumatic Drugs and the Newest Small Molecule Inhibitors.

Authors:  Blas Y Betancourt; Ann Biehl; James D Katz; Ananta Subedi
Journal:  Rheum Dis Clin North Am       Date:  2018-06-12       Impact factor: 2.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.